Gyre Therapeutics
GYRE
#5622
Rank
C$1.43 B
Marketcap
$16.72
Share price
0.09%
Change (1 day)
2.47%
Change (1 year)

EPS for Gyre Therapeutics (GYRE)

EPS in 2024 (TTM): $0.14

According to Gyre Therapeutics's latest financial reports the company's current EPS (TTM) is -$2.05. In 2023 the company made an earnings per share (EPS) of -$2.05 a decrease over its 2022 EPS that were of $0.006330.

EPS history for Gyre Therapeutics from 2021 to 2024

Annual EPS

Year EPS Change
2024 (TTM)$0.14-107%
2023-$2.05-32451.8%
2022$0.006330-90.93%
2021$0.06975